While tumor mutation burden (TMB) has been considered as a biomarker for predicting cancer progression and treatment outcome [23], physiological mismatch repair (MMR) proteins aim to detect and correct errors in mismatched nucleotides, the defects of which can lead to microsatellite instability (MSI) in DNA [24]. The gene discussed is MRC1; the disease is cancer.